These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 30538005

  • 21. Hypoxia causes increased monocyte nitric oxide synthesis which is mediated by changes in dimethylarginine dimethylaminohydrolase 2 expression in animal and human models of normobaric hypoxia.
    Lambden S, Martin D, Vanezis K, Lee B, Tomlinson J, Piper S, Boruc O, Mythen M, Leiper J.
    Nitric Oxide; 2016 Aug 31; 58():59-66. PubMed ID: 27319282
    [Abstract] [Full Text] [Related]

  • 22. Dimethylarginine Dimethylaminohydrolase 2 (DDAH 2) Gene Polymorphism, Asymmetric Dimethylarginine (ADMA) Concentrations, and Risk of Coronary Artery Disease: A Case-Control Study.
    Xuan C, Xu LQ, Tian QW, Li H, Wang Q, He GW, Lun LM.
    Sci Rep; 2016 Sep 28; 6():33934. PubMed ID: 27677852
    [Abstract] [Full Text] [Related]

  • 23. Ex vivo gene transferring of human dimethylarginine dimethylaminohydrolase-2 improved endothelial dysfunction in diabetic rat aortas and high glucose-treated endothelial cells.
    Lu CW, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y.
    Atherosclerosis; 2010 Mar 28; 209(1):66-73. PubMed ID: 19775692
    [Abstract] [Full Text] [Related]

  • 24. Relationship between DDAH gene variants and serum ADMA level in individuals with type 1 diabetes.
    Fogarty RD, Abhary S, Javadiyan S, Kasmeridis N, Petrovsky N, Whiting MJ, Craig JE, Burdon KP.
    J Diabetes Complications; 2012 Mar 28; 26(3):195-8. PubMed ID: 22521321
    [Abstract] [Full Text] [Related]

  • 25. Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension.
    Pullamsetti S, Kiss L, Ghofrani HA, Voswinckel R, Haredza P, Klepetko W, Aigner C, Fink L, Muyal JP, Weissmann N, Grimminger F, Seeger W, Schermuly RT.
    FASEB J; 2005 Jul 28; 19(9):1175-7. PubMed ID: 15827267
    [Abstract] [Full Text] [Related]

  • 26. Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity.
    Garbin U, Pasini AF, Stranieri C, Manfro S, Boccioletti V, Cominacini L.
    Pharmacol Res; 2007 Dec 28; 56(6):515-21. PubMed ID: 17977009
    [Abstract] [Full Text] [Related]

  • 27. AGXT2 and DDAH-1 genetic variants are highly correlated with serum ADMA and SDMA levels and with incidence of coronary artery disease in Egyptians.
    Amir M, Hassanein SI, Abdel Rahman MF, Gad MZ.
    Mol Biol Rep; 2018 Dec 28; 45(6):2411-2419. PubMed ID: 30284143
    [Abstract] [Full Text] [Related]

  • 28. ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis.
    Tanhäuserová V, Tomandl J, Pácal L, Klepárník M, Malúšková D, Bartáková V, Kuricová K, Rehořová J, Stěpánková S, Svojanovský J, Olšovský J, Bělobrádková J, Krusová D, Jurajda M, Mužík J, Pavlík T, Kaňková K.
    Kidney Blood Press Res; 2012 Dec 28; 36(1):200-8. PubMed ID: 23147199
    [Abstract] [Full Text] [Related]

  • 29. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
    Hasegawa K, Wakino S, Tatematsu S, Yoshioka K, Homma K, Sugano N, Kimoto M, Hayashi K, Itoh H.
    Circ Res; 2007 Jul 20; 101(2):e2-10. PubMed ID: 17601800
    [Abstract] [Full Text] [Related]

  • 30. Asymmetric dimethylarginine and L-arginine levels in neonatal sepsis and septic shock.
    Aydemir O, Ozcan B, Yucel H, Bas AY, Demirel N.
    J Matern Fetal Neonatal Med; 2015 May 20; 28(8):977-82. PubMed ID: 24983667
    [Abstract] [Full Text] [Related]

  • 31. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML.
    J Affect Disord; 2004 Jun 20; 80(2-3):249-56. PubMed ID: 15207938
    [Abstract] [Full Text] [Related]

  • 32. Redefining the biological and pathophysiological role of dimethylarginine dimethylaminohydrolase 2.
    Nair PC, Mangoni AA, Rodionov RN.
    Trends Mol Med; 2024 Jun 20; 30(6):552-561. PubMed ID: 38553332
    [Abstract] [Full Text] [Related]

  • 33. Pharmacological activation of dimethylarginine dimethylaminohydrolase (DDAH) activity by inorganic nitrate and DDAH inhibition by NG-hydroxy-L-arginine, Nω,Nω-dimethyl-L-citrulline and Nω,Nω-dimethyl-Nδ-hydroxy-L-citrulline: results and overview.
    Bollenbach A, Tsikas D.
    Amino Acids; 2019 Mar 20; 51(3):483-494. PubMed ID: 30536052
    [Abstract] [Full Text] [Related]

  • 34. Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis.
    Dimitroulas T, Sandoo A, Hodson J, Smith J, Panoulas VF, Kitas GD.
    Atherosclerosis; 2014 Nov 20; 237(1):38-44. PubMed ID: 25194333
    [Abstract] [Full Text] [Related]

  • 35. Accelerated onset of senescence of endothelial progenitor cells in patients with type 2 diabetes mellitus: role of dimethylarginine dimethylaminohydrolase 2 and asymmetric dimethylarginine.
    Yuan Q, Hu CP, Gong ZC, Bai YP, Liu SY, Li YJ, Jiang JL.
    Biochem Biophys Res Commun; 2015 Mar 20; 458(4):869-76. PubMed ID: 25701782
    [Abstract] [Full Text] [Related]

  • 36. Increased asymmetric dimethylarginine (ADMA) dimethylaminohydrolase (DDAH) activity in childhood hypercholesterolemia type II.
    Chobanyan-Jürgens K, Fuchs AJ, Tsikas D, Kanzelmeyer N, Das AM, Illsinger S, Vaske B, Jordan J, Lücke T.
    Amino Acids; 2012 Aug 20; 43(2):805-11. PubMed ID: 22075968
    [Abstract] [Full Text] [Related]

  • 37. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
    Dayoub H, Rodionov RN, Lynch C, Cooke JP, Arning E, Bottiglieri T, Lentz SR, Faraci FM.
    Stroke; 2008 Jan 20; 39(1):180-4. PubMed ID: 18063827
    [Abstract] [Full Text] [Related]

  • 38. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.
    Ueda S, Kato S, Matsuoka H, Kimoto M, Okuda S, Morimatsu M, Imaizumi T.
    Circ Res; 2003 Feb 07; 92(2):226-33. PubMed ID: 12574151
    [Abstract] [Full Text] [Related]

  • 39. Dysfunction of endothelial NO system originated from homocysteine-induced aberrant methylation pattern in promoter region of DDAH2 gene.
    Zhang JG, Liu JX, Li ZH, Wang LZ, Jiang YD, Wang SR.
    Chin Med J (Engl); 2007 Dec 05; 120(23):2132-7. PubMed ID: 18167189
    [Abstract] [Full Text] [Related]

  • 40. Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension.
    Maas R, Erdmann J, Lüneburg N, Stritzke J, Schwedhelm E, Meisinger C, Peters A, Weil J, Schunkert H, Böger RH, Lieb W.
    Pharmacol Res; 2009 Dec 05; 60(6):488-93. PubMed ID: 19666123
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.